Muscone Ameliorates Synaptic Dysfunction and Cognitive Deficits in APP/PS1 Mice

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Synaptic plasticity dysfunction is a key factor in Alzheimer's disease (AD) related memory impairment.
• Muscone (Mus) demonstrates neuroprotective properties in cerebral ischemia, but its role in AD is largely unexplored.

Purpose of the Study:

• To evaluate the impact of Muscone on memory and synaptic plasticity in a mouse model of Alzheimer's disease (APP/PS1 mice).
• To elucidate the underlying molecular mechanisms of Muscone's effects in AD.

Main Methods:

• Cognitive function was assessed using Novel Object Recognition and Morris Water Maze tests.
• Amyloid-beta (Aβ) levels, synaptic morphology, and plasticity were quantified.
• Histone deacetylase 2 (HDAC2) levels, ubiquitination, and interactions were analyzed using biochemical and computational methods.

Main Results:

• Muscone treatment significantly improved memory deficits and enhanced synaptic plasticity in APP/PS1 mice.
• Muscone reduced amyloid-beta levels and decreased HDAC2 expression in the hippocampus.
• Increased HDAC2 ubiquitination, potentially mediated by Muscone interaction, was observed.

Conclusions:

• Muscone demonstrates therapeutic potential for Alzheimer's disease by mitigating memory impairment and synaptic dysfunction.
• The mechanism involves HDAC2 degradation via ubiquitination, highlighting a novel therapeutic pathway.